Bulletin
Investor Alert

Intercept Pharmaceuticals Inc.

NAS: ICPT

GO
/marketstate/country/us

After Hours

/zigman2/quotes/202434567/composite

$

17.17

Change

+0.35 +2.08%

Volume

Volume 9,654

May 25, 2022, 5:28 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/202434567/composite

Today's close

$ 16.62

$ 16.82

Change

+0.20 +1.20%

Day low

Day high

$16.41

$17.12

Open
Open: 16.62

52 week low

52 week high

$11.60

$22.36

Open

Market cap

$493.76M

Average volume

1.07M

P/E ratio

N/A

Rev. per Employee

$847,572

EPS

-2.26

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/icpt

MarketWatch News on ICPT

  1. Intercept Pharmaceuticals stock price target cut to $31 from $43 at Canaccord Genuity

    9:22 a.m. Aug. 3, 2021

    - Tomi Kilgore

  2. The FDA's Biogen Decision Will Cause Waves Across Biotech

    9:20 p.m. June 1, 2021

    - Barron's Online

  3. Intercept Pharmaceuticals downgraded to neutral from buy at B. Riley

    7:23 a.m. May 26, 2021

    - Tomi Kilgore

  4. Intercept Pharmaceuticals stock price target cut to $74 from $97 at B. Riley FBR

    8:28 a.m. Nov. 20, 2020

    - Tomi Kilgore

  5. Intercept Pharmaceuticals upgraded to outperform from market perform at Raymond James

    8:47 a.m. Nov. 10, 2020

    - Tomi Kilgore

  6. Intercept shares gain after it announces layoffs

    8:19 a.m. Sept. 2, 2020

    - Jaimy Lee

  7. A Top Contender Drops Out of Race for a NASH Drug

    11:15 a.m. July 23, 2020

    - Barron's Online

  8. Biogen Submits Troubled Alzheimer’s Drug for FDA Approval

    12:07 p.m. July 8, 2020

    - Barron's Online

  9. Analysts Are Downgrading Intercept Pharmaceuticals. Here’s Why.

    11:53 a.m. June 30, 2020

    - Barron's Online

  10. Intercept Pharmaceuticals downgraded to market perform at BMO Capital

    9:07 a.m. June 30, 2020

    - Tomi Kilgore

  11. Intercept Pharmaceuticals stock price target cut to $97 from $158 at B. Riley FBR

    7:53 a.m. June 30, 2020

    - Tomi Kilgore

  12. Intercept Pharmaceuticals stock price target cut to $50 from $89 at SVB Leerink

    6:11 a.m. June 30, 2020

    - Tomi Kilgore

  13. Intercept Shares Tumble on NASH Disappointment

    4:05 p.m. June 29, 2020

    - Barron's Online

  14. Intercept's stock plunges 35% premarket after receiving CRL from FDA for treatment of fibrosis due to NASH

    7:17 a.m. June 29, 2020

    - Tomi Kilgore

  15. Intercept Pharmaceuticals receives FDA letter for its treatment for fibrosis due to NASH

    7:15 a.m. June 29, 2020

    - Ciara Linnane

  16. Intercept Pharmaceuticals shares slide 35% premarket

    7:15 a.m. June 29, 2020

    - Ciara Linnane

  17. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/icpt

Other News on ICPT

  1. Intercept: Increase Of Ocaliva Sales And A Few Catalysts

    3:47 p.m. May 23, 2022

    - Seeking Alpha

  2. 10-Q: INTERCEPT PHARMACEUTICALS, INC.

    4:08 p.m. May 6, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  3. BRCC and CYN among mid-day movers

    1:02 p.m. May 5, 2022

    - Seeking Alpha

  4. Intercept Pharma Q1 2022 Earnings Preview

    12:06 p.m. May 5, 2022

    - Seeking Alpha

  5. Notable earnings before Friday's open

    10:41 a.m. May 5, 2022

    - Seeking Alpha

  6. Madrigal: Clear Path Ahead

    2:09 p.m. April 22, 2022

    - Seeking Alpha

  7. Loading more headlines...
/news/pressrelease/company/us/icpt

Press Releases on ICPT

  1. Chau Khuong Joins Catalio Capital Management as General Partner

    3:00 p.m. Today

    - BusinessWire - BZX

  2. Global Psychedelics Market Is Expected To Reach $8 Billion By 2029

    8:53 a.m. May 24, 2022

    - Financial News Media

  3. Global Psychedelics Market Is Expected To Reach $8 Billion By 2029

    8:50 a.m. May 24, 2022

    - PR Newswire - PRF

  4. Loading more headlines...

Rates »

Link to MarketWatch's Slice.